FDA SCRUTINIZES OFF-LABEL PROMOTIONS

被引：7
作者：
RANDALL, T
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1991年 / 266卷 / 01期
关键词：
D O I：
10.1001/jama.266.1.11
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
[41]   Off-label prescribing [J].
Gazarian, Madlen ;
Morris, Steve .
MEDICAL JOURNAL OF AUSTRALIA, 2014, 200 (11) :637-637
[42]   Off-label on the table [J].
Pitts, Peter J. .
Journal of Commercial Biotechnology, 2015, 21 (03) :8-12
[43]   Off-label prescribing [J].
Kelly, Maria ;
Gazarian, Madlen ;
McPhee, John .
AUSTRALIAN PRESCRIBER, 2005, 28 (01) :7-7
[44]   A status for off-label [J].
Derrien, Elisa .
ACTUALITES PHARMACEUTIQUES, 2019, 58 (582) :6-6
[45]   OFF-LABEL PREEMPTION [J].
Simon, David A. .
WISCONSIN LAW REVIEW, 2024, (03) :1080-1147
[46]   OFF-LABEL PRESCRIBING OF ANTIDEPRESSANTS Robust systems are needed for off-label prescribing [J].
Ross, Samantha .
BMJ-BRITISH MEDICAL JOURNAL, 2017, 356
[47]   Off-Label Use vs Off-Label Marketing Part 2: Off-Label Marketing- Consequences for Patients, Clinicians, and Researchers [J].
Van Norman, Gail A. .
JACC-BASIC TO TRANSLATIONAL SCIENCE, 2023, 8 (03) :359-370
[48]   Off-label or Off-limits? [J].
Ritchey, Michael L. .
JOURNAL OF UROLOGY, 2013, 190 (01) :8-9
[49]   Off-label or off-limits? [J].
Mark Ratner ;
Trisha Gura .
Nature Biotechnology, 2008, 26 :867-875
[50]   Off-label or off-limits? [J].
Ratner, Mark ;
Gura, Trisha .
NATURE BIOTECHNOLOGY, 2008, 26 (08) :867-875
12345